Medical publication policies and guidelines offer a framework for best practices, but there may be situations when more than one approach seems reasonable. The primary purpose of “What Would You Do?” is to explore examples of such situations. With the limited...
ISMPP Launches the 2026 GenAI in Practice Survey A year can be a long time in generative AI. In September 2025, ISMPP members participated in the first GenAI in Practice Survey, helping establish a benchmark for how generative AI was being adopted and applied across...
Perspectives from ISMPP Insider’s Expert Successes Initiative, a forum for sharing practical experiences and insights. As expectations for transparency and accessibility in scientific publishing continue to rise, Plain Language Summaries of Publications (PLS-Ps)...
You are a writer at a medical communications agency supporting development of the first draft of a manuscript reporting primary results from a phase 3 clinical trial. At your client’s request, you are using the pharmaceutical company’s internally developed...
Clear, accessible communication is fundamental to high-quality medical communications. That’s why ISMPP is proud to support the use of the Multi-Regional Clinical Trials (MRCT) Center’s Clinical Research Glossary, a patient-centered, consensus-driven resource...
